Relmada Therapeutics RLMD
NASDAQ RLMD
$3.27 -0.02 (-0.61%)
At close: Oct 23, 2026 · 4:00 PM EDT

Relmada Therapeutics (RLMD) Amortization of Deferred Charges (2017 - 2019)

Updated

Analysis

Relmada Therapeutics (RLMD) Amortization of Deferred Charges (2017 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Relmada Therapeutics 367.47 Mn -191.12 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 1.00
Dec 31, 2018 124,647.00
Sep 30, 2018 536,520.00
Jun 30, 2018 527,980.00
Mar 31, 2018 293,422.00
Dec 31, 2017 204,962.00
Sep 30, 2017 2,819.00
API Access

Relmada Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=RLMD&period=max&api_key=YOUR_API_KEY